Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F03A9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,583
Award facts
- Contract value 100% obligated
- $47,583.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,583.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2mL pen format on January 12, 2026, with completion targeted for January 13, 2026. This competitive award carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement.
This delivery order falls within the broader scope of DLA's pharmaceutical supply chain supporting military healthcare systems worldwide. Cosentyx is a biologic immunosuppressant indicated for autoimmune conditions, reflecting the Defense Logistics Agency's procurement of specialized pharmaceutical products needed by military treatment facilities and veteran healthcare programs. The award demonstrates AmerisourceBergen's ongoing role as a primary pharmaceutical vendor for the Department of Defense, delivering prescription medications and medical supplies across multiple therapeutic domains in support of federal medical operations.
Quick answers
Who was awarded contract SPE2DR26F03A9?
SPE2DR26F03A9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F03A9 worth?
The government has obligated $47,583 on SPE2DR26F03A9.
Is contract SPE2DR26F03A9 an order under another contract?
Yes. SPE2DR26F03A9 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03A9 competed?
The extent of competition for SPE2DR26F03A9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award